SLN

Silence Therapeutics
SLN

Overview Fund Activity

28 hedge funds and large institutions have $188M invested in Silence Therapeutics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 5 closing their positions.

Holders
28
Holders Change
-1
Holders Change %
-3.45%
% of All Funds
0.45%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
4
Increased
4
Reduced
7
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AG
1
Artal Group
Luxembourg
$24.6M
2
LCM
2
Lynx1 Capital Management
Puerto Rico
$2.32M
3
LOAME
3
Lombard Odier Asset Management (Europe)
United Kingdom
$33.8M
4
PHP
4
Parkman Healthcare Partners
Connecticut
$1.89M
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$210K

Top Sellers

1
Goldman Sachs
1
Goldman Sachs
New York
$2.62M
2
CF
2
Cantor Fitzgerald
New York
$1.65M
3
WP
3
Woodline Partners
California
$1.64M
4
LOAMU
4
Lombard Odier Asset Management (USA)
New York
$33.7M
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Qube Research & Technologies (QRT)
26
Qube Research & Technologies (QRT)
United Kingdom
$1.75K +$1.75K +178 New
SPIA
27
Steward Partners Investment Advisory
New York
$982 – – –
RhumbLine Advisers
28
RhumbLine Advisers
Massachusetts
$49 +$49 +5 New
Point72 Asset Management
29
Point72 Asset Management
Connecticut
– -$477K -86,700 Closed
Axa
30
Axa
France
– -$322K -58,624 Closed
Millennium Management
31
Millennium Management
New York
– -$126K -22,832 Closed
TRCT
32
Tower Research Capital (TRC)
New York
– -$4.4K -800 Closed
Osaic Holdings
33
Osaic Holdings
Arizona
– -$27 -5 Closed
1
2